VIBRANT: VIB4920 for Active Lupus Nephritis

(

VIBRANT

)

ITN Protocol #:

ITN091AI

Branded Name:

VIBRANT

ClinicalTrials.Gov ID:

NCT05201469

Treatment Protocol #:

Therapeutic Area:

Autoimmune Disease

Current Status:

Enrollment

ITN Website Clinical Trial Recruiting Site Document Portal Location Study on ITN TrialShare

Summary:

A Phase 2a Randomized Placebo-Controlled Double-Blind Multicenter Trial of VIB4920 for Active Lupus Nephritis

Clinical Operations Associate Director

Clinical Operations Manager

ITN Biologist

ITN Clinical Trial Physician

NIAID Project Manager

NIAID Regulator Officer

Rho Data Manager

Rho Scientist

PPD Lead Monitor

Study Personnel:

Protocol Chair

Maria Dall'era, MD maria.dallera@ucsf.edu

Work:

415-476-0783

Protocol Chair

Betty Diamond, MD bdiamond@nshs.edu

Work:

516-562-3830

Protocol Chair

David Wofsy, MD wofsyd@medsch.ucsf.edu

Work:

415-750-2104

Protocol Chair

Patti Tosta ptosta@immunetolerance.org

Work:

415-353-4421

Protocol Chair

Kristin Ryker kryker@immunetolerance.org

Work:

415-353-4405

Protocol Chair

Laura Cooney, PhD lcooney@immunetolerance.org

Work:

734-274-1149

Protocol Chair

Dawn Smilek, MD PhD dsmilek@immunetolerance.org

Work:

415-353-4308

Protocol Chair

Wendy Gao gaowe@mail.nih.gov

Work:

240-627-3471

Protocol Chair

Ling Li, PhD lil16@niaid.nih.gov

Work:

240-627-3765

Protocol Chair

Michele Cosgrove michele_cosgrove@rhoworld.com

Work:

919-595-6445

Protocol Chair

Traci Leong traci_leong@rhoworld.com

Work:

Protocol Chair

Amanda Miles amanda.miles@ppd.com

Work: